SK130893A3 - Pyrrole derivatives, method of their preparation and their pharmaceutical use - Google Patents

Pyrrole derivatives, method of their preparation and their pharmaceutical use Download PDF

Info

Publication number
SK130893A3
SK130893A3 SK1308-93A SK130893A SK130893A3 SK 130893 A3 SK130893 A3 SK 130893A3 SK 130893 A SK130893 A SK 130893A SK 130893 A3 SK130893 A3 SK 130893A3
Authority
SK
Slovakia
Prior art keywords
dihydro
formula
pyrrole
group
imidazol
Prior art date
Application number
SK1308-93A
Other languages
English (en)
Slovak (sk)
Inventor
Mireille Sevrin
Jacques Menin
Christian Maloizel
Martin J A Diaz
Escudero P U Martin
Zurita M Bedoya
Sol Moreno G Del
Bargueno M D Jimenez
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9214065A external-priority patent/FR2698364B1/fr
Priority claimed from FR9307538A external-priority patent/FR2706899A1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of SK130893A3 publication Critical patent/SK130893A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1308-93A 1992-11-24 1993-11-23 Pyrrole derivatives, method of their preparation and their pharmaceutical use SK130893A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214065A FR2698364B1 (fr) 1992-11-24 1992-11-24 Dérivés de pyrrole, leur préparation et leur application en thérapeutique.
FR9307538A FR2706899A1 (en) 1993-06-22 1993-06-22 Pyrrole derivatives, their preparation and their therapeutic application

Publications (1)

Publication Number Publication Date
SK130893A3 true SK130893A3 (en) 1994-11-09

Family

ID=26229898

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1308-93A SK130893A3 (en) 1992-11-24 1993-11-23 Pyrrole derivatives, method of their preparation and their pharmaceutical use

Country Status (16)

Country Link
US (1) US5380742A (de)
EP (1) EP0599697A1 (de)
JP (1) JPH06211869A (de)
KR (1) KR940011466A (de)
CN (1) CN1091743A (de)
AU (1) AU662846B2 (de)
CA (1) CA2109774A1 (de)
CZ (1) CZ252193A3 (de)
FI (1) FI935196A7 (de)
HU (1) HUT70504A (de)
IL (1) IL107726A (de)
MX (1) MX9307309A (de)
NO (1) NO934227L (de)
NZ (1) NZ250258A (de)
PL (1) PL301143A1 (de)
SK (1) SK130893A3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719844B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.
DE19514579A1 (de) 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
MXPA00010805A (es) * 1998-05-06 2002-05-08 Univ Duke Metodo para el tratamiento de sindromes de la vejiga y del tracto urinario inferior.
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
JP2004035507A (ja) * 2002-07-05 2004-02-05 Nippon Soda Co Ltd ピロール誘導体及びその製造方法
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
DE4023048A1 (de) * 1990-07-20 1992-01-23 Basf Ag Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
AU664710B2 (en) * 1991-08-27 1995-11-30 Upjohn Company, The A method for treatment of metabolic disorders
US5252581A (en) * 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use

Also Published As

Publication number Publication date
PL301143A1 (en) 1994-05-30
MX9307309A (es) 1994-06-30
NO934227D0 (no) 1993-11-23
AU662846B2 (en) 1995-09-14
KR940011466A (ko) 1994-06-21
CN1091743A (zh) 1994-09-07
EP0599697A1 (de) 1994-06-01
JPH06211869A (ja) 1994-08-02
IL107726A (en) 1997-01-10
NZ250258A (en) 1995-07-26
HU9303322D0 (en) 1994-03-28
AU5183193A (en) 1994-06-09
US5380742A (en) 1995-01-10
FI935196A0 (fi) 1993-11-23
IL107726A0 (en) 1994-02-27
FI935196L (fi) 1994-05-25
FI935196A7 (fi) 1994-05-25
CA2109774A1 (fr) 1994-05-25
CZ252193A3 (en) 1994-06-15
NO934227L (no) 1994-05-25
HUT70504A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
EP3893871B1 (de) Benzimidazolonderivate und analoge davon als il-17-modulatoren
AU2017371200B2 (en) Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Davis et al. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity
EP3040331B1 (de) Tetrahydrocyclopentapyrrolderivat und herstellungsverfahren dafür
CA3239343A1 (en) Quinazoline pan-kras inhibitors
EP4712961A2 (de) Kras-g12s- und g12c-hemmer
EP1945222B1 (de) Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamine als igf-1r-kinasehemmer zur behandlung von krebs und anderen hyperproliferativen erkrankungen
JP3410478B2 (ja) 三環性ピロール若しくはピラゾール誘導体
EP3440082A1 (de) Monofunktionelle zwischenprodukte für den ligandenabhängigen zielproteinabbau
NO179283B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
EP0188094A2 (de) Chinazolinderivate und diese als wirksame Bestandteile enthaltende antihypertensive Zubereitungen
EP0401030A2 (de) Angiotensin II-Antagonisten
KR20180128907A (ko) 면역조절제로서 작용하는 트리시클릭 화합물 (tricyclic compound serving as immunomodulator)
SK130893A3 (en) Pyrrole derivatives, method of their preparation and their pharmaceutical use
HU197576B (en) Process for production of new 2-tiazolil-imidazo /1,2-a/ piramidines and medical compositions containing these substances
WO2011083316A1 (en) Benzazepine derivatives for the treatment of central nervous system disorders
CN116057061A (zh) Usp7抑制剂
AU2013358167A1 (en) Hydantoin derivative
HUP9904514A2 (hu) 5H-Pirrolo[2,1-c][1,4]-benzodiazepin-3-karboxamid-származékok, eljárás előállításukra, alkalmazásuk és az azokat tartalmazó gyógyszerkészítmények
EP0540209A1 (de) Imidazolderivate und diese enthaltende Arzneimittel
CA3222502A1 (en) Benzoxazinone derivatives
EP0313288B1 (de) Imidazol-Derivate, Verfahren zu deren Herstellung und deren Anwendung als alpha-2-Adrenoceptor-Antagonisten
JPH10287678A5 (de)
HK1001174B (en) Imidazole derivatives, process for their preparation and their use as alpha 2-adreno-receptor antagonists
HUT72667A (en) 5,6-dihydro-4h-thieno[3,4-c]pyrrol derivatives, process for producing them and pharmaceutical compositions containing them